Cell Growth & Differentiation, Vol 8, Issue 10 1061-1069, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Osteopontin expression in mammary gland development and tumorigenesis

SR Rittling and KE Novick
Department of Cell, Developmental, and Neurobiology, Rutgers University, Piscataway, New Jersey 08855, USA. rittling@mbcl.rutgers.edu

Osteopontin (OPN) is a secreted phosphoprotein that binds to cells via an Arg-Gly-Asp sequence and to mineralized surfaces. The protein can mediate cell adhesion and is strongly implicated in transformation and tumorigenesis. We have examined the expression pattern of OPN in mouse mammary glands at different stages of postnatal development. Whereas OPN is expressed at low-to-moderate levels in mammary glands from virgin and pregnant mice, the levels of OPN mRNA are extremely high in the lactating gland, consistent with the presence of the protein in milk. Expression is highest at 2 days of lactation and declines thereafter, but it remains high through involution. OPN expression is restricted to small nests or groups of cells at 9 days of involution. These results suggest that OPN may play a specific role in the process of involution that may be distinct from its role during lactation. In mammary tumors arising spontaneously in transgenic mice expressing the oncogenes c-myc and/or v-Ha-ras under the control of the mouse mammary tumor virus promoter, the level of OPN expression is increased dramatically over that in the normal gland in these same animals. Numerous cells expressing OPN mRNA are widespread throughout the tumors. OPN protein is detectable by Western blotting in extracts from the mammary gland at 2 days of lactation and from the tumors, but not in mammary glands at other stages of development. We hypothesize that OPN is exported from most tissues and that the protein is only detectable in tissues elaborating fluids, such as the lactating mammary gland, or in pathological situations when expression of OPN is abnormally high, such as in tumors.

This article has been cited by other articles:

				P.-L. Chang, L. Harkins, Y.-H. Hsieh, P. Hicks, K. Sappayatosok, S. Yodsanga, S. Swasdison, A. F. Chambers, C. A. Elmets, and K.-J. Ho Osteopontin Expression in Normal Skin and Non-melanoma Skin Tumors J. Histochem. Cytochem., January 1, 2008; 56(1): 57 - 66. [Abstract] [Full Text] [PDF]

				L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097. [Abstract] [Full Text] [PDF]

				I. Vietor, R. Kurzbauer, G. Brosch, and L. A. Huber TIS7 Regulation of the {beta}-Catenin/Tcf-4 Target Gene Osteopontin (OPN) Is Histone Deacetylase-dependent J. Biol. Chem., December 2, 2005; 280(48): 39795 - 39801. [Abstract] [Full Text] [PDF]

				J. Briese, M. Oberndorfer, C. Patschenik, H. M. Schulte, A. Makrigiannakis, T. Loning, and A.-M. Bamberger Osteopontin Is Colocalized with the Adhesion Molecule CEACAM1 in the Extravillous Trophoblast of the Human Placenta and Enhances Invasion of CEACAM1-Expressing Placental Cells J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5407 - 5413. [Abstract] [Full Text] [PDF]

				R. D. Schnabel, J.-J. Kim, M. S. Ashwell, T. S. Sonstegard, C. P. Van Tassell, E. E. Connor, and J. F. Taylor Fine-mapping milk production quantitative trait loci on BTA6: Analysis of the bovine osteopontin gene PNAS, May 10, 2005; 102(19): 6896 - 6901. [Abstract] [Full Text] [PDF]

				G. A. Johnson, R. C. Burghardt, F. W. Bazer, and T. E. Spencer Osteopontin: Roles in Implantation and Placentation Biol Reprod, November 1, 2003; 69(5): 1458 - 1471. [Abstract] [Full Text] [PDF]

				E. Geissinger, C. Weisser, P. Fischer, M. Schartl, and C. Wellbrock Autocrine Stimulation by Osteopontin Contributes to Antiapoptotic Signalling of Melanocytes in Dermal Collagen Cancer Res., August 15, 2002; 62(16): 4820 - 4828. [Abstract] [Full Text] [PDF]

				P. S. Rudland, A. Platt-Higgins, M. El-Tanani, S. de Silva Rudland, R. Barraclough, J. H. R. Winstanley, R. Howitt, and C. R. West Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer Cancer Res., June 1, 2002; 62(12): 3417 - 3427. [Abstract] [Full Text] [PDF]

				S. R. Rittling, Y. Chen, F. Feng, and Y. Wu Tumor-derived Osteopontin Is Soluble, Not Matrix Associated J. Biol. Chem., March 8, 2002; 277(11): 9175 - 9182. [Abstract] [Full Text] [PDF]

				M. El-Tanani, D. G. Fernig, R. Barraclough, C. Green, and P. Rudland Differential Modulation of Transcriptional Activity of Estrogen Receptors by Direct Protein-Protein Interactions with the T Cell Factor Family of Transcription Factors J. Biol. Chem., November 2, 2001; 276(45): 41675 - 41682. [Abstract] [Full Text] [PDF]

				G. A. Johnson, R. C. Burghardt, T. E. Spencer, G. R. Newton, T. L. Ott, and F. W. Bazer Ovine Osteopontin: II. Osteopontin and {alpha}v{beta}3 Integrin Expression in the Uterus and Conceptus During the Periimplantation Period Biol Reprod, October 1, 1999; 61(4): 892 - 899. [Abstract] [Full Text]